Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Tianjiang Pharmaceutical is a pioneer and leader in the field of Traditional Chinese Medicine (TCM) formula granules. Established in 1992, the company was the first in China to receive national approval for the research and production of standardized TCM granules, which serve as a modern alternative to traditional herbal decoctions. As a core subsidiary of China Traditional Chinese Medicine Holdings (China TCM) under the Sinopharm group, Tianjiang maintains rigorous quality control through advanced fingerprinting technology and GMP-certified facilities. Their product portfolio includes over 700 varieties of single-herb granules used extensively in clinical settings across China and exported to over 30 countries. The company's business model focuses on the entire TCM industrial chain, from standardized cultivation of herbs to high-tech extraction and clinical application.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tian Jiang.